ACADIAN ASSET MANAGEMENT LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 916542 Boston, MA

Position in BCYC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$9,131,636

-$2,700,870 QoQ

Shares Held

1,968,025

+17.8% QoQ

Ownership

2.81%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. BCYC ranks #14 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,131,636	1,968,025	+17.8%	Shares	Defined	2026-05-13
2025-12-31	$11,832,506	1,671,258	+27.1%	Shares	Defined	2026-02-10
2025-09-30	$10,174,663	1,314,556	+88.2%	Shares	Defined	2025-11-13
2025-06-30	$4,854,581	698,501	+454.1%	Shares	Defined	2025-08-07
2025-03-31	$1,070,266	126,062	+121.5%	Shares	Defined	2025-05-21
2022-06-30	$954,933	56,909	+58.3%	Shares	Defined	2022-08-09
2022-03-31	$1,577,880	35,959	-79.9%	Shares	Defined	2022-05-12
2021-12-31	$10,867,668	178,539	+743.2%	Shares	Defined	2022-02-10
2021-09-30	$880,626	21,174	+136.5%	Shares	Defined	2021-11-12
2021-06-30	$271,813	8,953	-76.7%	Shares	Defined	2021-08-11
2021-03-31	$1,148,800	38,460	+236.5%	Shares	Defined	2021-05-11
2020-12-31	$205,186	11,431	—	Shares	Defined	2021-02-11
No filing history on record for this holder in this stock.